retatrutide efficacy weight loss Lilly's shows 28% loss, but increased side effects Retatrutide Side Effects Guide: 21

Neither approach is universally superior

Use of Ozempic, a GLP-1 medication approved by the Food and Drug Administration (FDA) to treat diabetes, is increasing 75% (or $6.7 billion in spending) on a rolling 12-month average.1 This type of snowballing drug spend, if left unchecked, can cause plan premiums to soar, potentially pricing out members, leaving people who need drug coverage without the ability to pay for it

For people who deal with restrictive eating, the goal of eating disorder treatment is usually to return to normal eating habits and shift focus away from weight loss

The high levels of patient satisfaction speak to their effectiveness, as more clients share their success stories with others seeking similar transformations